AMPYRA

Product NDC: 10144-427
11-digit product format: 101440427
Labeler code: 10144
Product ID: 10144-427_dda9045d-2f23-412c-9543-74832f421739
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dalfampridine
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Merz Pharmaceuticals, LLC
Application: NDA022250
Marketing category: NDA
Marketing start: 2010-03-01
Substance: DALFAMPRIDINE
Active strength: 10 mg/1
Pharmacologic classes: Potassium Channel Antagonists [MoA], Potassium Channel Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022250-001	AMPYRA	DALFAMPRIDINE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N022250-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022250-001	AMPYRA	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS	2010-01-22	`e64feba35796…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	N022250-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022250-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022250-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022250-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022250-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022250-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022250-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022250-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022250-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022250-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022250-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022250-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022250-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022250-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022250-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022250-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022250-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022250-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022250-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022250-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022250-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022250-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022250-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022250-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022250-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022250-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022250-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022250-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022250-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022250-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022250-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022250-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022250-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022250-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022250-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022250-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022250-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022250-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022250-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022250-001	AB	1	`e64feba35796…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N022250-001	8440703	2025-04-08	U-1030	Delist requested	2013-06-12	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022250-001	8354437	2026-12-22	U-1030	Delist requested	2013-02-13	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022250-001	8007826	2027-05-26	U-1030	Delist requested	2011-09-28	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N022250-001	8440703	2025-04-08	U-1030	Delist requested	2013-06-12	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022250-001	8354437	2026-12-22	U-1030	Delist requested	2013-02-13	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022250-001	8007826	2027-05-26	U-1030	Delist requested	2011-09-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022250-001	9918973	2024-12-13	U-1030		2018-04-17	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022250-001	8663685	2025-01-18	U-1030		2014-04-02	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022250-001	8440703	2025-04-08	U-1030		2013-06-12	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022250-001	8354437	2026-12-22	U-1030		2013-02-13	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022250-001	8007826	2027-05-26	U-1030		2011-09-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022250-001	9918973	2024-12-13	U-1030		2018-04-17	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022250-001	8663685	2025-01-18	U-1030		2014-04-02	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022250-001	8440703	2025-04-08	U-1030		2013-06-12	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022250-001	8354437	2026-12-22	U-1030		2013-02-13	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022250-001	8007826	2027-05-26	U-1030		2011-09-28	`ea99ee380514…`

Additional Listing Data#

Finished product: Yes
Brand name base: AMPYRA
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DALFAMPRIDINE	10 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
BH3B64OKL9	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
897021	Internal RxNorm lookup
897025	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9109832c-cb3c-b72f-db80-0e6688f08431	Product name	5	20190619

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10144-427-60	AMPYRA	60 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	60		22

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10144-427-60	EA - Each	10144-427	efcd7340-55b3-4f6f-a82f-d4690ba04aa5	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DALFAMPRIDINE	ACTIVE INGREDIENT	BH3B64OKL9	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
DALFAMPRIDINE	ACTIVE MOIETY	BH3B64OKL9	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [ACORDA THERAPEUTICS, INC.]	8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10144-427	AMPYRA (DALFAMPRIDINE) TABLET, FILM COATED, EXTENDED RELEASE [MERZ PHARMACEUTICALS, LLC]	21	Current NDC, Legacy NDC, 1 package rows	20241222_550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AMPYRA	DALFAMPRIDINE	Merz Pharmaceuticals, LLC	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	2026-01-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022250 application number: NDA022250 ndc (product): 10144-427
AMPYRA	DALFAMPRIDINE	Merz Pharmaceuticals, LLC	974fb2af-7012-4989-b330-e44a31c9c3e5	2025-05-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022250 application number: NDA022250

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
BH3B64OKL9	DALFAMPRIDINE	504-24-5	DALFAMPRIDINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
897025	Ampyra 10 MG 12HR Extended Release Oral Tablet	PSN	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897021	dalfampridine 10 MG 12HR Extended Release Oral Tablet	PSN	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897025	12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra]	SBD	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897021	12 HR dalfampridine 10 MG Extended Release Oral Tablet	SCD	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897025	12 HR Ampyra 10 MG Extended Release Oral Tablet	SY	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897025	Ampyra 10 MG 12 HR Extended Release Oral Tablet	SY	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22
897021	dalfampridine 10 MG 12 HR Extended Release Oral Tablet	SY	550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783	22

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
10144-427-60	10144042760	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60)	2010-03-01	0000-00-00	No	No	Current